MetaADEDB 2.0 @ LMMD
Levofloxacin
(GSDSWSVVBLHKDQ-JTQLQIEISA-N)
Structure
SMILES
CN1CCN(CC1)c1c(F)cc2c3c1OC[C@@H](n3cc(c2=O)C(=O)O)C
Type(s)
Approved; Investigational
ATC code(s)
A02BD10; J01MA12; J01RA05; S01AE05
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.368
Log P:
1.5469
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
75.01
CAS Number(s):
100986-85-4
Synonym(s)
1.
Levofloxacin
2.
Levaquin
3.
Levofloxacin Anhydrous
4.
Ofloxacin, (S)-Isomer
5.
Quixin
6.
Anhydrous, Levofloxacin
External Link(s)
MeSHD064704
PubChem Compound149096
6956357
BindingDB50366826
ChEBI63598
CHEMBLCHEMBL33
DrugBankDB01137
DrugCentral1569
KEGGcpd:C07660
dr:D08120
Therapeutic Target DatabaseD02RSN
ZINC538273
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Aortic AneurysmFAERS: 1828US FAERS
2ArthralgiaFAERS: 1786
Canada Vigilance: 14
Canada Vigilance
US FAERS
3Rotator cuff syndromeFAERS: 1047
Canada Vigilance: 3
Canada Vigilance
US FAERS
4PainFAERS: 875
Canada Vigilance: 5
Canada Vigilance
US FAERS
5MyalgiaFAERS: 805
Canada Vigilance: 9
Canada Vigilance
US FAERS
6DizzinessFAERS: 587
Canada Vigilance: 6
Canada Vigilance
US FAERS
7Musculoskeletal PainFAERS: 538
Canada Vigilance: 2
Canada Vigilance
US FAERS
8AstheniaFAERS: 517
Canada Vigilance: 3
Canada Vigilance
US FAERS
9AnxietyFAERS: 506
Canada Vigilance: 6
Canada Vigilance
US FAERS
10NauseaFAERS: 494
Canada Vigilance: 8
Canada Vigilance
US FAERS
11FatigueFAERS: 470
Canada Vigilance: 2
Canada Vigilance
US FAERS
12HeadacheFAERS: 466
Canada Vigilance: 8
Canada Vigilance
US FAERS
13PruritusFAERS: 406
Canada Vigilance: 4
Canada Vigilance
US FAERS
14Joint swellingFAERS: 388
Canada Vigilance: 5
Canada Vigilance
US FAERS
15UrticariaFAERS: 354
Canada Vigilance: 5
Canada Vigilance
US FAERS
16Feeling abnormalFAERS: 326
Canada Vigilance: 1
Canada Vigilance
US FAERS
17TremorFAERS: 326
Canada Vigilance: 6
Canada Vigilance
US FAERS
18Burning sensationFAERS: 304
Canada Vigilance: 2
Canada Vigilance
US FAERS
19HypersensitivityFAERS: 297
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Back PainFAERS: 293
Canada Vigilance: 2
Canada Vigilance
US FAERS
21AbasiaFAERS: 289US FAERS
22Joint injuryFAERS: 278
Canada Vigilance: 1
Canada Vigilance
US FAERS
23ErythemaFAERS: 268US FAERS
24MalaiseFAERS: 261
Canada Vigilance: 1
Canada Vigilance
US FAERS
25VomitingFAERS: 254
Canada Vigilance: 5
Canada Vigilance
US FAERS
26TenosynovitisFAERS: 251
Canada Vigilance: 2
Canada Vigilance
US FAERS
27PalpitationsFAERS: 241
Canada Vigilance: 5
Canada Vigilance
US FAERS
28SwellingFAERS: 235US FAERS
29Drug ineffectiveFAERS: 234
Canada Vigilance: 4
Canada Vigilance
US FAERS
30Musculoskeletal stiffnessFAERS: 225
Canada Vigilance: 1
Canada Vigilance
US FAERS
31TinnitusFAERS: 214
Canada Vigilance: 1
Canada Vigilance
US FAERS
32EpicondylitisFAERS: 211US FAERS
33Visual ImpairmentFAERS: 207
Canada Vigilance: 1
Canada Vigilance
US FAERS
34ArthropathyFAERS: 194
Canada Vigilance: 3
Canada Vigilance
US FAERS
35Impaired work abilityFAERS: 191
Canada Vigilance: 1
Canada Vigilance
US FAERS
36BursitisFAERS: 188US FAERS
37Ligament ruptureFAERS: 179US FAERS
38Chest PainFAERS: 172
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Activities of daily living impairedFAERS: 168US FAERS
40nervous system disorderFAERS: 142US FAERS
41Neck PainFAERS: 139US FAERS
42Weight decreasedFAERS: 137
Canada Vigilance: 2
Canada Vigilance
US FAERS
43ArthritisFAERS: 134US FAERS
44Abdominal PainFAERS: 129US FAERS
45TachycardiaFAERS: 125US FAERS
46Joint stiffnessFAERS: 116
Canada Vigilance: 1
Canada Vigilance
US FAERS
47Stevens-Johnson SyndromeFAERS: 116
Canada Vigilance: 2
25811541CTD
Canada Vigilance
US FAERS
48Adverse eventFAERS: 112US FAERS
49ChillsFAERS: 110
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Carpal Tunnel SyndromeFAERS: 104
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Memory impairmentFAERS: 95US FAERS
52AgitationFAERS: 92
Canada Vigilance: 1
Canada Vigilance
US FAERS
53DeliriumFAERS: 89US FAERS
54DisorientationFAERS: 86US FAERS
55RestlessnessFAERS: 85US FAERS
56DisabilityFAERS: 83
Canada Vigilance: 1
Canada Vigilance
US FAERS
57AlopeciaFAERS: 82US FAERS
58AmnesiaFAERS: 82
Canada Vigilance: 1
Canada Vigilance
US FAERS
59DysgeusiaFAERS: 81
Canada Vigilance: 1
Canada Vigilance
US FAERS
60PeriarthritisFAERS: 81US FAERS
61Peripheral swellingFAERS: 78
Canada Vigilance: 2
Canada Vigilance
US FAERS
62NervousnessFAERS: 77
Canada Vigilance: 1
Canada Vigilance
US FAERS
63Chest discomfortFAERS: 75US FAERS
64HypotensionFAERS: 75US FAERS
65Abdominal discomfortFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
66Joint Range of Motion DecreasedFAERS: 74US FAERS
67Rash erythematousFAERS: 72
Canada Vigilance: 2
Canada Vigilance
US FAERS
68SyncopeFAERS: 72
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Toxicity to various agentsFAERS: 72
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Nerve injuryFAERS: 71
Canada Vigilance: 1
Canada Vigilance
US FAERS
71Muscle tightnessFAERS: 70
Canada Vigilance: 3
Canada Vigilance
US FAERS
72DehydrationFAERS: 67US FAERS
73VertigoFAERS: 66US FAERS
74ConstipationFAERS: 63US FAERS
75BedriddenFAERS: 61US FAERS
76CryingFAERS: 61US FAERS
77InflammationFAERS: 61
Canada Vigilance: 2
Canada Vigilance
US FAERS
78Atrial FibrillationFAERS: 60US FAERS
79DysphoniaFAERS: 59US FAERS
80Eye painFAERS: 58US FAERS
81NeuralgiaFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
82AgeusiaFAERS: 57US FAERS
83PneumoniaFAERS: 57
Canada Vigilance: 3
Canada Vigilance
US FAERS
84AngioedemaFAERS: 56
Canada Vigilance: 2
Canada Vigilance
US FAERS
85Bone painFAERS: 56
Canada Vigilance: 1
Canada Vigilance
US FAERS
86Muscle strainFAERS: 56US FAERS
87Toxic Epidermal NecrolysisFAERS: 56
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Anaphylactic shockFAERS: 55US FAERS
89FibromyalgiaFAERS: 55US FAERS
90muscle injuryFAERS: 55US FAERS
91Impaired driving abilityFAERS: 54US FAERS
92DiscomfortFAERS: 52US FAERS
93SomnolenceFAERS: 50US FAERS
94Unevaluable eventFAERS: 50US FAERS
95BlindnessFAERS: 49US FAERS
96DeafnessFAERS: 49US FAERS
97FlushingFAERS: 49US FAERS
98Lip swellingFAERS: 49
Canada Vigilance: 3
Canada Vigilance
US FAERS
99PresyncopeFAERS: 49US FAERS
100SynovitisFAERS: 47US FAERS
101AnorexiaFAERS: 46US FAERS
102Joint sprainFAERS: 46US FAERS
103Respiratory distressFAERS: 46
Canada Vigilance: 2
Canada Vigilance
US FAERS
104Cartilage injuryFAERS: 45US FAERS
105InfectionFAERS: 45US FAERS
106Product quality issueFAERS: 45US FAERS
107Walking aid userFAERS: 45US FAERS
108ParanoiaFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
109Respiratory FailureFAERS: 44US FAERS
110SinusitisFAERS: 43US FAERS
111StressFAERS: 43US FAERS
112DyspepsiaFAERS: 42US FAERS
113AnosmiaFAERS: 41US FAERS
114Cardiac ArrestFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
115HypokinesiaFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
116Kounis SyndromeFAERS: 41US FAERS
117Night sweatsFAERS: 41US FAERS
118Quality of life decreasedFAERS: 41US FAERS
119OverdoseFAERS: 40US FAERS
120Infusion site erythemaFAERS: 39US FAERS
121MyoclonusFAERS: 39US FAERS
122RhabdomyolysisFAERS: 39
Canada Vigilance: 2
Canada Vigilance
US FAERS
123Gait inabilityFAERS: 38US FAERS
124LethargyFAERS: 38US FAERS
125Cerebrovascular accidentFAERS: 37US FAERS
126Musculoskeletal discomfortFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
127MyositisFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
128Rheumatoid ArthritisFAERS: 37
Canada Vigilance: 4
Canada Vigilance
US FAERS
129AngerFAERS: 36US FAERS
130General physical health deteriorationFAERS: 36US FAERS
131Thermal burnFAERS: 36US FAERS
132Deep Vein ThrombosisFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
133Drug resistanceFAERS: 35US FAERS
134ThrombosisFAERS: 35US FAERS
135Incorrect dose administeredFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
136Limb injuryFAERS: 34US FAERS
137Urinary tract infectionFAERS: 34US FAERS
138Limb discomfortFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
139Middle insomniaFAERS: 33US FAERS
140PhotophobiaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
141Visual disturbanceFAERS: 33US FAERS
142Grip strength decreasedFAERS: 32US FAERS
143Mental status changesFAERS: 32US FAERS
144Oropharyngeal painFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
145AphasiaFAERS: 31US FAERS
146Drug toxicityFAERS: 31US FAERS
147Pulmonary EmbolismFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
148SepsisFAERS: 31US FAERS
149Cold sweatFAERS: 30US FAERS
150DiplopiaFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Injection site erythemaFAERS: 30US FAERS
152ThrombocytopeniaFAERS: 30
Canada Vigilance: 5
Canada Vigilance
US FAERS
153BronchospasmFAERS: 29US FAERS
154Medication ErrorFAERS: 29US FAERS
155PolyneuropathyFAERS: 29US FAERS
156ShockFAERS: 29US FAERS
157Vitreous floatersFAERS: 29US FAERS
158AsthmaFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
159EpilepsyFAERS: 28US FAERS
160Myocardial InfarctionFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
161Back disorderFAERS: 27US FAERS
162Emotional disorderFAERS: 27US FAERS
163BronchitisFAERS: 26US FAERS
164Skin lesionFAERS: 26US FAERS
165Status EpilepticusFAERS: 26US FAERS
166Alanine Aminotransferase IncreasedFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Blood glucose decreasedFAERS: 25US FAERS
168DysuriaFAERS: 25US FAERS
169InfluenzaFAERS: 25US FAERS
170Internal injuryFAERS: 25US FAERS
171Meniscus injuryFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Musculoskeletal chest painFAERS: 25US FAERS
173Temperature intoleranceFAERS: 25US FAERS
174Urinary IncontinenceFAERS: 25US FAERS
175WheezingFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
176ChromaturiaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Drug prescribing errorFAERS: 24US FAERS
178Loss of personal independence in daily activitiesFAERS: 24US FAERS
179RetchingFAERS: 24US FAERS
180Blood glucose increasedFAERS: 23US FAERS
181ColitisFAERS: 23US FAERS
182Depressed Level of ConsciousnessFAERS: 23US FAERS
183Drug dose omissionFAERS: 23US FAERS
184HypophagiaFAERS: 23US FAERS
185PallorFAERS: 23US FAERS
186Wheelchair userFAERS: 23US FAERS
187Acute kidney injuryFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
188Feeling ColdFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
189Injection site pruritusFAERS: 22US FAERS
190Mental impairmentFAERS: 22US FAERS
191Product use issueFAERS: 22US FAERS
192Blood creatinine increasedFAERS: 21US FAERS
193DysarthriaFAERS: 21US FAERS
194EosinophiliaFAERS: 21US FAERS
195Feeling of body temperature changeFAERS: 21US FAERS
196FlatulenceFAERS: 21US FAERS
197Ligament injuryFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
198Muscle FatigueFAERS: 21US FAERS
199PneumonitisFAERS: 21US FAERS
200StomatitisFAERS: 21US FAERS
201Tendon discomfortFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
202jaundiceFAERS: 21US FAERS
203treatment failureFAERS: 21US FAERS
204CholestasisFAERS: 20US FAERS
205Dry skinFAERS: 20US FAERS
206Emotional distressFAERS: 20US FAERS
207Feeling jitteryFAERS: 20US FAERS
208FormicationFAERS: 20US FAERS
209HyperventilationFAERS: 20US FAERS
210Vanishing bile duct syndromeFAERS: 20US FAERS
211Depressed moodFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
212Drug exposure during pregnancyFAERS: 19US FAERS
213HypoxiaFAERS: 19US FAERS
214Inappropriate schedule of drug administrationFAERS: 19US FAERS
215LeukopeniaFAERS: 19US FAERS
216Pharmaceutical product complaintFAERS: 19US FAERS
217Post-Traumatic Stress DisorderFAERS: 19US FAERS
218Ankle FractureFAERS: 18US FAERS
219Aspartate Aminotransferase IncreasedFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
220BradycardiaFAERS: 18US FAERS
221Ear discomfortFAERS: 18US FAERS
222Eye irritationFAERS: 18US FAERS
223GoutFAERS: 18US FAERS
224ImmobileFAERS: 18US FAERS
225Infusion site pruritusFAERS: 18US FAERS
226Ligament painFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
227Muscle RigidityFAERS: 18US FAERS
228Shoulder PainFAERS: 18US FAERS
229Throat irritationFAERS: 18US FAERS
230Ventricular FibrillationFAERS: 18US FAERS
231AbscessFAERS: 17US FAERS
232Unresponsive to stimuliFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
233Altered state of consciousnessFAERS: 16US FAERS
234Blood alkaline phosphatase increasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
235Blood potassium decreasedFAERS: 16US FAERS
236Clostridium difficile colitisFAERS: 16US FAERS
237Eosinophilic PneumoniaFAERS: 16US FAERS
238GastritisFAERS: 16US FAERS
239HepatitisFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
240HyperacusisFAERS: 16US FAERS
241NeutropeniaFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
242Oral painFAERS: 16US FAERS
243Poor quality sleepFAERS: 16US FAERS
244Product substitution issueFAERS: 16US FAERS
245Skin UlcerFAERS: 16US FAERS
246ThirstFAERS: 16US FAERS
247Blood creatine phosphokinase increasedFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
248ExtravasationFAERS: 15US FAERS
249IndurationFAERS: 15US FAERS
250LymphadenopathyFAERS: 15US FAERS
251Multiple allergiesFAERS: 15US FAERS
252NeuropathyFAERS: 15US FAERS
253Product use in unapproved indicationFAERS: 15US FAERS
254Psychiatric symptomFAERS: 15US FAERS
255Synovial CystFAERS: 15US FAERS
256White blood cell count decreasedFAERS: 15US FAERS
257Acute psychosisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Bipolar DisorderFAERS: 14US FAERS
259Choking sensationFAERS: 14US FAERS
260Economic problemFAERS: 14US FAERS
261Erythema MultiformeFAERS: 14US FAERS
262HyperpyrexiaFAERS: 14US FAERS
263Infusion Site ExtravasationFAERS: 14US FAERS
264Infusion site painFAERS: 14US FAERS
265Multiple SclerosisFAERS: 14US FAERS
266Pain of skinFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
267Pathogen resistanceFAERS: 14US FAERS
268Restless Legs SyndromeFAERS: 14US FAERS
269Septic ShockFAERS: 14US FAERS
270CellulitisFAERS: 13US FAERS
271Eosinophilic myocarditisFAERS: 13US FAERS
272EpistaxisFAERS: 13US FAERS
273Foreign body aspirationFAERS: 13US FAERS
274Infusion site rashFAERS: 13US FAERS
275Mood swingsFAERS: 13US FAERS
276Optic NeuritisFAERS: 13US FAERS
277PhlebitisFAERS: 13US FAERS
278PoisoningFAERS: 13US FAERS
279Retinal DetachmentFAERS: 13US FAERS
280SunburnFAERS: 13US FAERS
281Acute respiratory failureFAERS: 12US FAERS
282BlepharospasmFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
283Clostridium difficile infectionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
284Completed SuicideFAERS: 12US FAERS
285CyanosisFAERS: 12US FAERS
286DementiaFAERS: 12US FAERS
287HypersomniaFAERS: 12US FAERS
288Initial insomniaFAERS: 12US FAERS
289LeukocytosisFAERS: 12US FAERS
290MyosclerosisFAERS: 12US FAERS
291NoduleFAERS: 12US FAERS
292Pharyngolaryngeal PainFAERS: 12US FAERS
293Product counterfeitFAERS: 12US FAERS
294PurpuraFAERS: 12US FAERS
295ScreamingFAERS: 12US FAERS
296Angina PectorisFAERS: 11US FAERS
297Bursa injuryFAERS: 11US FAERS
298ChokingFAERS: 11US FAERS
299CystitisFAERS: 11US FAERS
300EcchymosisFAERS: 11US FAERS
301Gastrointestinal PainFAERS: 11US FAERS
302Head discomfortFAERS: 11US FAERS
303HepatotoxicityFAERS: 11US FAERS
304Infusion site reactionFAERS: 11US FAERS
305Post procedural complicationFAERS: 11US FAERS
306Respiratory arrestFAERS: 11US FAERS
307Sensory level abnormalFAERS: 11US FAERS
308Suicide attemptFAERS: 11US FAERS
309ToothacheFAERS: 11US FAERS
310Acute myocardial infarctionFAERS: 10US FAERS
311AphoniaFAERS: 10US FAERS
312DeformityFAERS: 10US FAERS
313Diabetes MellitusFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
314Drug administration errorFAERS: 10US FAERS
315Drug dispensing errorFAERS: 10US FAERS
316Gamma-Glutamyltransferase IncreasedFAERS: 10US FAERS
317Hallucinations, mixedFAERS: 10US FAERS
318IncoherentFAERS: 10US FAERS
319Injection Site ReactionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
320Myasthenia GravisFAERS: 10US FAERS
321MyopathyFAERS: 10US FAERS
322Neuralgic AmyotrophyFAERS: 10US FAERS
323PetechiaeFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
324PolyarthritisFAERS: 10US FAERS
325Skin reactionFAERS: 10US FAERS
326SneezingFAERS: 10US FAERS
327VasculitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
328Vitreous DetachmentFAERS: 10US FAERS
329Accidental overdoseFAERS: 9US FAERS
330Anaphylactoid ReactionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
331Blood pressure fluctuationFAERS: 9US FAERS
332Blood sodium decreasedFAERS: 9US FAERS
333Blood urea increasedFAERS: 9US FAERS
334CystFAERS: 9US FAERS
335DermatitisFAERS: 9US FAERS
336DissociationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
337EczemaFAERS: 9US FAERS
338Erectile dysfunctionFAERS: 9US FAERS
339Genital burning sensationFAERS: 9US FAERS
340Impaired quality of lifeFAERS: 9US FAERS
341NeuritisFAERS: 9US FAERS
342Osmotic demyelination syndromeFAERS: 9US FAERS
343Renal painFAERS: 9US FAERS
344SciaticaFAERS: 9US FAERS
345Supraventricular tachycardiaFAERS: 9US FAERS
346Time perception alteredFAERS: 9US FAERS
347Transaminases increasedFAERS: 9US FAERS
348Wrong technique in drug usage processFAERS: 9US FAERS
349AtaxiaFAERS: 8US FAERS
350BlepharitisFAERS: 8US FAERS
351CandidiasisFAERS: 8US FAERS
352CataractFAERS: 8US FAERS
353CholelithiasisFAERS: 8US FAERS
354Disease recurrenceFAERS: 8US FAERS
355DiverticulitisFAERS: 8US FAERS
356Drug abuseFAERS: 8US FAERS
357DystoniaFAERS: 8US FAERS
358Facial PainFAERS: 8US FAERS
359Guillain-Barre SyndromeFAERS: 8US FAERS
360HemiplegiaFAERS: 8US FAERS
361HepatomegalyFAERS: 8US FAERS
362IncontinenceFAERS: 8US FAERS
363Intentional drug misuseFAERS: 8US FAERS
364Mitochondrial toxicityFAERS: 8US FAERS
365Mixed liver injuryFAERS: 8US FAERS
366Multiple Chemical SensitivityFAERS: 8US FAERS
367NasopharyngitisFAERS: 8US FAERS
368Oral candidiasisFAERS: 8US FAERS
369Oropharyngeal swellingFAERS: 8US FAERS
370Pancreatic enzymes increasedFAERS: 8US FAERS
371PancreatitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
372Purpura FulminansFAERS: 8US FAERS
373Sinus TachycardiaFAERS: 8US FAERS
374Therapy non-responderFAERS: 8US FAERS
375Vulvovaginal mycotic infectionFAERS: 8US FAERS
376AnuriaFAERS: 7US FAERS
377AphagiaFAERS: 7US FAERS
378Autoimmune hepatitisFAERS: 7US FAERS
379Autonomic nervous system imbalanceFAERS: 7US FAERS
380Bronchial ObstructionFAERS: 7US FAERS
381Candida endophthalmitisFAERS: 7US FAERS
382DysenteryFAERS: 7US FAERS
383Electrolyte imbalanceFAERS: 7US FAERS
384EructationFAERS: 7US FAERS
385Erythema NodosumFAERS: 7US FAERS
386Food AllergyFAERS: 7US FAERS
387FrustrationFAERS: 7US FAERS
388HerniaFAERS: 7US FAERS
389HoarsenessFAERS: 7US FAERS
390Hypoaesthesia facialFAERS: 7US FAERS
391Irritable Bowel SyndromeFAERS: 7US FAERS
392Lymphomatoid PapulosisFAERS: 7US FAERS
393MonoplegiaFAERS: 7US FAERS
394Muscle CrampFAERS: 7US FAERS
395No adverse eventFAERS: 7US FAERS
396No reaction on previous exposure to drugFAERS: 7US FAERS
397Nodular rashFAERS: 7US FAERS
398Obsessive-Compulsive DisorderFAERS: 7US FAERS
399Ocular icterusFAERS: 7US FAERS
400PapuleFAERS: 7US FAERS
401Polymyalgia RheumaticaFAERS: 7US FAERS
402Poor peripheral circulationFAERS: 7US FAERS
403Prescribed overdoseFAERS: 7US FAERS
404SplenomegalyFAERS: 7US FAERS
405Tongue discomfortFAERS: 7US FAERS
406Vocal Cord ParalysisFAERS: 7US FAERS
407Wrong technique in product usage processFAERS: 7US FAERS
408AkinesiaFAERS: 6US FAERS
409AllodyniaFAERS: 6US FAERS
410AtelectasisFAERS: 6US FAERS
411Blood cholesterol increasedFAERS: 6US FAERS
412Blood urine presentFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
413Cardiac FlutterFAERS: 6US FAERS
414Clostridium colitisFAERS: 6US FAERS
415ConjunctivitisFAERS: 6US FAERS
416Conversion disorderFAERS: 6US FAERS
417Disseminated Intravascular CoagulationFAERS: 6US FAERS
418Drug ineffective for unapproved indicationFAERS: 6US FAERS
419DysgraphiaFAERS: 6US FAERS
420Electrocardiogram QT interval abnormalFAERS: 6US FAERS
421Escherichia sepsisFAERS: 6US FAERS
422Euphoric moodFAERS: 6US FAERS
423ExophthalmosFAERS: 6US FAERS
424Expired product administeredFAERS: 6US FAERS
425Fixed drug eruptionFAERS: 6US FAERS
426GangreneFAERS: 6US FAERS
427General physical condition decreasedFAERS: 6US FAERS
428Graft infectionFAERS: 6US FAERS
429Head titubationFAERS: 6US FAERS
430HypertransaminasaemiaFAERS: 6US FAERS
431HypogeusiaFAERS: 6US FAERS
432Inadequate analgesiaFAERS: 6US FAERS
433Injection site extravasationFAERS: 6US FAERS
434LacerationFAERS: 6US FAERS
435Leukocytoclastic vasculitisFAERS: 6US FAERS
436Lupus-like syndromeFAERS: 6US FAERS
437MalnutritionFAERS: 6US FAERS
438Mouth swellingFAERS: 6US FAERS
439Nonspecific reactionFAERS: 6US FAERS
440PancytopeniaFAERS: 6US FAERS
441Personality ChangeFAERS: 6US FAERS
442Physical disabilityFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
443PneumothoraxFAERS: 6US FAERS
444PrurigoFAERS: 6US FAERS
445Radial nerve palsyFAERS: 6US FAERS
446RhonchiFAERS: 6US FAERS
447Sense of oppressionFAERS: 6US FAERS
448Skeletal injuryFAERS: 6US FAERS
449Skin lacerationFAERS: 6US FAERS
450Sleep disorder due to general medical condition, insomnia typeFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
451SoporFAERS: 6US FAERS
452Stasis dermatitisFAERS: 6US FAERS
453StridorFAERS: 6US FAERS
454Tarsal Tunnel SyndromeFAERS: 6US FAERS
455TorticollisFAERS: 6US FAERS
456Troponin increasedFAERS: 6US FAERS
457Urinary RetentionFAERS: 6US FAERS
458VIIth nerve paralysisFAERS: 6US FAERS
459Vascular purpuraFAERS: 6US FAERS
460Ventricular arrhythmiaFAERS: 6US FAERS
461Wrong drug administeredFAERS: 6US FAERS
462AcneFAERS: 5US FAERS
463ApathyFAERS: 5US FAERS
464Apparent deathFAERS: 5US FAERS
465AsthenopiaFAERS: 5US FAERS
466Blood blisterFAERS: 5US FAERS
467Blood glucose abnormalFAERS: 5US FAERS
468Blood glucose fluctuationFAERS: 5US FAERS
469BunionFAERS: 5US FAERS
470CapillaritisFAERS: 5US FAERS
471Cardiac discomfortFAERS: 5US FAERS
472Cardiac ventricular thrombosisFAERS: 5US FAERS
473Cerebral InfarctionFAERS: 5US FAERS
474ClonusFAERS: 5US FAERS
475Crystal nephropathyFAERS: 5US FAERS
476Disease ProgressionFAERS: 5US FAERS
477Electrocardiogram abnormalFAERS: 5US FAERS
478Electroencephalogram abnormalFAERS: 5US FAERS
479Enterocolitis bacterialFAERS: 5US FAERS
480Febrile NeutropeniaFAERS: 5US FAERS
481Fixed eruptionFAERS: 5US FAERS
482FractureFAERS: 5US FAERS
483Gastrointestinal motility disorderFAERS: 5US FAERS
484Gaze palsyFAERS: 5US FAERS
485General physical condition abnormalFAERS: 5US FAERS
486Impaired self-careFAERS: 5US FAERS
487Incorrect drug administration rateFAERS: 5US FAERS
488Increased tendency to bruiseFAERS: 5US FAERS
489Iron deficiencyFAERS: 5US FAERS
490Joint warmthFAERS: 5US FAERS
491LaryngospasmFAERS: 5US FAERS
492Lichen PlanusFAERS: 5US FAERS
493LigamentitisFAERS: 5US FAERS
494Mitochondrial cytopathyFAERS: 5US FAERS
495Morbid thoughtsFAERS: 5US FAERS
496MydriasisFAERS: 5US FAERS
497ObstructionFAERS: 5US FAERS
498Open woundFAERS: 5US FAERS
499Panic DisorderFAERS: 5US FAERS
500Pelvic PainFAERS: 5US FAERS
501Peripheral artery thrombosisFAERS: 5US FAERS
502Posterior capsule ruptureFAERS: 5US FAERS
503Product label issueFAERS: 5US FAERS
504QuadriparesisFAERS: 5US FAERS
505Retinal Vein OcclusionFAERS: 5US FAERS
506StuporFAERS: 5US FAERS
507Therapeutic product cross-reactivityFAERS: 5US FAERS
508TrismusFAERS: 5US FAERS
509Ulnar tunnel syndromeFAERS: 5US FAERS
510Urinary hesitationFAERS: 5US FAERS
511Vascular ruptureFAERS: 5US FAERS
512Vibratory sense increasedFAERS: 5US FAERS
513Vitreous opacitiesFAERS: 5US FAERS
514pseudomembranous colitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
515Acute polyneuropathyFAERS: 4US FAERS
516Amyotrophic Lateral SclerosisFAERS: 4US FAERS
517AneurysmFAERS: 4US FAERS
518Anorectal discomfortFAERS: 4US FAERS
519AscitesFAERS: 4US FAERS
520AsphyxiaFAERS: 4US FAERS
521Band sensationFAERS: 4US FAERS
522Bed restFAERS: 4US FAERS
523Blood creatine increasedFAERS: 4US FAERS
524BradyphreniaFAERS: 4US FAERS
525Central nervous system lesionFAERS: 4US FAERS
526Cerebral disorderFAERS: 4US FAERS
527CheilitisFAERS: 4US FAERS
528Chronic Fatigue SyndromeFAERS: 4US FAERS
529Contraindicated drug administeredFAERS: 4US FAERS
530Documented hypersensitivity to administered drugFAERS: 4US FAERS
531EnthesopathyFAERS: 4US FAERS
532Full blood count abnormalFAERS: 4US FAERS
533GastroenteritisFAERS: 4US FAERS
534GlossitisFAERS: 4US FAERS
535Hepatic necrosisFAERS: 4US FAERS
536Hormone level abnormalFAERS: 4US FAERS
537Hypermobility syndromeFAERS: 4US FAERS
538Hypertensive crisisFAERS: 4US FAERS
539HypothyroidismFAERS: 4US FAERS
540Infusion site swellingFAERS: 4US FAERS
541Infusion site urticariaFAERS: 4US FAERS
542MacroglossiaFAERS: 4US FAERS
543Muscle SpasticityFAERS: 4US FAERS
544Negative thoughtsFAERS: 4US FAERS
545NephrolithiasisFAERS: 4US FAERS
546OphthalmoplegiaFAERS: 4US FAERS
547Orthosis userFAERS: 4US FAERS
548Palmar erythemaFAERS: 4US FAERS
549PapillomaFAERS: 4US FAERS
550PharyngitisFAERS: 4US FAERS
551Platelet aggregation abnormalFAERS: 4US FAERS
552PolymyositisFAERS: 4US FAERS
553Post-traumatic painFAERS: 4US FAERS
554Product size issueFAERS: 4US FAERS
555Productive CoughFAERS: 4US FAERS
556ProteinuriaFAERS: 4US FAERS
557PsoriasisFAERS: 4US FAERS
558Rectal tenesmusFAERS: 4US FAERS
559ScabFAERS: 4US FAERS
560Serum SicknessFAERS: 4US FAERS
561Similar reaction on previous exposure to drugFAERS: 4US FAERS
562Skin tightnessFAERS: 4US FAERS
563Vitamin D DeficiencyFAERS: 4US FAERS
564Vulvovaginal pruritusFAERS: 4US FAERS
565White matter lesionFAERS: 4US FAERS
566effusionFAERS: 4US FAERS
567furuncleFAERS: 4US FAERS
568Abdominal rigidityFAERS: 3US FAERS
569Abdominal tendernessFAERS: 3US FAERS
570Accidental exposureFAERS: 3US FAERS
571Acoustic NeuromaFAERS: 3US FAERS
572Allergy to chemicalsFAERS: 3US FAERS
573Atrial FlutterFAERS: 3US FAERS
574Bilirubin conjugated increasedFAERS: 3US FAERS
575Bipolar I disorderFAERS: 3US FAERS
576Blood count abnormalFAERS: 3US FAERS
577Blood immunoglobulin E increasedFAERS: 3US FAERS
578Blood magnesium decreasedFAERS: 3US FAERS
579Brain DeathFAERS: 3US FAERS
580Bronchial HyperreactivityFAERS: 3US FAERS
581BruxismFAERS: 3US FAERS
582Capillary FragilityFAERS: 3US FAERS
583Capillary Leak SyndromeFAERS: 3US FAERS
584Carotid Artery ThrombosisFAERS: 3US FAERS
585Cerebral calcificationFAERS: 3US FAERS
586Chest wall painFAERS: 3US FAERS
587ChondromalaciaFAERS: 3US FAERS
588ClaustrophobiaFAERS: 3US FAERS
589Deafness NeurosensoryFAERS: 3US FAERS
590Diabetes mellitus inadequate controlFAERS: 3US FAERS
591Documented hypersensitivity to administered productFAERS: 3US FAERS
592DroolingFAERS: 3US FAERS
593Drug screen positiveFAERS: 3US FAERS
594DysbacteriosisFAERS: 3US FAERS
595DyslexiaFAERS: 3US FAERS
596DysphemiaFAERS: 3US FAERS
597Educational problemFAERS: 3US FAERS
598EmbolismFAERS: 3US FAERS
599FasciitisFAERS: 3US FAERS
600Gastrointestinal infectionFAERS: 3US FAERS
601Hepatic EncephalopathyFAERS: 3US FAERS
602HungerFAERS: 3US FAERS
603HyperreflexiaFAERS: 3US FAERS
604HyporeflexiaFAERS: 3US FAERS
605Iliotibial Band SyndromeFAERS: 3US FAERS
606Incorrect drug administration durationFAERS: 3US FAERS
607Infective tenosynovitisFAERS: 3US FAERS
608Infusion site phlebitisFAERS: 3US FAERS
609Injection site painFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
610Intentional product misuseFAERS: 3US FAERS
611Intentional product use issueFAERS: 3US FAERS
612Joint capsule ruptureFAERS: 3US FAERS
613Lumbar radiculopathyFAERS: 3US FAERS
614Medical device complicationFAERS: 3US FAERS
615MonocytosisFAERS: 3US FAERS
616Nasal discomfortFAERS: 3US FAERS
617NecrosisFAERS: 3US FAERS
618NephritisFAERS: 3US FAERS
619Nephrotic SyndromeFAERS: 3US FAERS
620Nipple painFAERS: 3US FAERS
621No adverse effectFAERS: 3US FAERS
622Obsessive thoughtsFAERS: 3US FAERS
623Oral fungal infectionFAERS: 3US FAERS
624Palpable purpuraFAERS: 3US FAERS
625ParesisFAERS: 3US FAERS
626Patellofemoral Pain SyndromeFAERS: 3US FAERS
627Performance status decreasedFAERS: 3US FAERS
628PlagueFAERS: 3US FAERS
629PolydipsiaFAERS: 3US FAERS
630Post procedural infectionFAERS: 3US FAERS
631Product availability issueFAERS: 3US FAERS
632Psychotic symptomFAERS: 3US FAERS
633PurulenceFAERS: 3US FAERS
634QuadriplegiaFAERS: 3US FAERS
635Renal ColicFAERS: 3US FAERS
636Respiratory DepressionFAERS: 3US FAERS
637Retinal Vascular DisorderFAERS: 3US FAERS
638Reversed hot-cold sensationFAERS: 3US FAERS
639ScotomaFAERS: 3US FAERS
640Sexual DysfunctionFAERS: 3US FAERS
641Sinus headacheFAERS: 3US FAERS
642Sinus operationFAERS: 3US FAERS
643StaringFAERS: 3US FAERS
644TachyphreniaFAERS: 3US FAERS
645Temperature regulation disorderFAERS: 3US FAERS
646Tendon necrosisFAERS: 3US FAERS
647TensionFAERS: 3US FAERS
648Therapeutic product ineffectiveFAERS: 3US FAERS
649Therapeutic response unexpectedFAERS: 3US FAERS
650UlcerFAERS: 3US FAERS
651UrethritisFAERS: 3US FAERS
652Uterine ProlapseFAERS: 3US FAERS
653Vaginal DischargeFAERS: 3US FAERS
654Venous thrombosis limbFAERS: 3US FAERS
655XanthopsiaFAERS: 3US FAERS
656prostatitisFAERS: 3US FAERS
657Acquired gene mutationFAERS: 2US FAERS
658Acute sinusitisFAERS: 2US FAERS
659AgoraphobiaFAERS: 2US FAERS
660AgranulocytosisFAERS: 2US FAERS
661AkathisiaFAERS: 2US FAERS
662AmyloidosisFAERS: 2US FAERS
663Ankle impingementFAERS: 2US FAERS
664Anoxic EncephalopathyFAERS: 2US FAERS
665Aortic RuptureFAERS: 2US FAERS
666Apparent life threatening eventFAERS: 2US FAERS
667ArthrofibrosisFAERS: 2US FAERS
668Arthropod biteFAERS: 2US FAERS
669Atrial tachycardiaFAERS: 2US FAERS
670Autonomic neuropathyFAERS: 2US FAERS
671BabesiosisFAERS: 2US FAERS
672Bladder painFAERS: 2US FAERS
673Blood albumin increasedFAERS: 2US FAERS
674Blood amylase increasedFAERS: 2US FAERS
675Blood fibrinogen increasedFAERS: 2US FAERS
676Blood lactate dehydrogenase increasedFAERS: 2US FAERS
677Blood potassium increasedFAERS: 2US FAERS
678Blood triglycerides increasedFAERS: 2US FAERS
679Body temperature fluctuationFAERS: 2US FAERS
680Bone infarctionFAERS: 2US FAERS
681Bone oedemaFAERS: 2US FAERS
682Bowel movement irregularityFAERS: 2US FAERS
683Catheter related complicationFAERS: 2US FAERS
684Cell DeathFAERS: 2US FAERS
685Cervicobrachial syndromeFAERS: 2US FAERS
686ChromatopsiaFAERS: 2US FAERS
687Cluster HeadacheFAERS: 2US FAERS
688CoccidioidomycosisFAERS: 2US FAERS
689Concomitant disease aggravatedFAERS: 2US FAERS
690Creatinine renal clearance decreasedFAERS: 2US FAERS
691Cubital Tunnel SyndromeFAERS: 2US FAERS
692Cutaneous sarcoidosisFAERS: 2US FAERS
693Depression suicidalFAERS: 2US FAERS
694Device malfunctionFAERS: 2US FAERS
695Dissociative Identity DisorderFAERS: 2US FAERS
696Drug level decreasedFAERS: 2US FAERS
697Drug screen false positiveFAERS: 2US FAERS
698Eczema impetiginousFAERS: 2US FAERS
699Electrocardiogram QT corrected intervalFAERS: 2US FAERS
700Electrocardiogram changeFAERS: 2US FAERS
701Electromechanical dissociationFAERS: 2US FAERS
702EncephalitisFAERS: 2US FAERS
703EndophthalmitisFAERS: 2US FAERS
704EnterocolitisFAERS: 2US FAERS
705ErysipelasFAERS: 2US FAERS
706ErythromelalgiaFAERS: 2US FAERS
707Escherichia infectionFAERS: 2US FAERS
708Exposure during breast feedingFAERS: 2US FAERS
709Eye InfectionFAERS: 2US FAERS
710Eye infection intraocularFAERS: 2US FAERS
711Fascial ruptureFAERS: 2US FAERS
712Flank PainFAERS: 2US FAERS
713Flat affectFAERS: 2US FAERS
714Flight of ideasFAERS: 2US FAERS
715Food cravingFAERS: 2US FAERS
716Foreign body sensation in eyesFAERS: 2US FAERS
717Frustration tolerance decreasedFAERS: 2US FAERS
718Gastrointestinal carcinomaFAERS: 2US FAERS
719Genital rashFAERS: 2US FAERS
720GlaucomaFAERS: 2US FAERS
721GranulomaFAERS: 2US FAERS
722Hand-eye coordination impairedFAERS: 2US FAERS
723Head BangingFAERS: 2US FAERS
724Hip surgeryFAERS: 2US FAERS
725Histiocytosis haematophagicFAERS: 2US FAERS
726HypercreatininaemiaFAERS: 2US FAERS
727HypoventilationFAERS: 2US FAERS
728Idiosyncratic drug reactionFAERS: 2US FAERS
729IleusFAERS: 2US FAERS
730Incision site complicationFAERS: 2US FAERS
731Incorrect product storageFAERS: 2US FAERS
732Inflammatory marker increasedFAERS: 2US FAERS
733Infusion site inflammationFAERS: 2US FAERS
734Injection site streakingFAERS: 2US FAERS
735Intercepted medication errorFAERS: 2US FAERS
736Intervertebral Disc DegenerationFAERS: 2US FAERS
737Intervertebral disc disorderFAERS: 2US FAERS
738Intracranial AneurysmFAERS: 2US FAERS
739Joint destructionFAERS: 2US FAERS
740LaryngitisFAERS: 2US FAERS
741Left Ventricular HypertrophyFAERS: 2US FAERS
742Lower respiratory tract infectionFAERS: 2US FAERS
743Lyme DiseaseFAERS: 2US FAERS
744Lymphocyte count decreasedFAERS: 2US FAERS
745Macular degenerationFAERS: 2US FAERS
746MalabsorptionFAERS: 2US FAERS
747Male sexual dysfunctionFAERS: 2US FAERS
748Mallory-Weiss SyndromeFAERS: 2US FAERS
749Mechanical urticariaFAERS: 2US FAERS
750Medial Tibial Stress SyndromeFAERS: 2US FAERS
751Meningeal disorderFAERS: 2US FAERS
752MetamorphopsiaFAERS: 2US FAERS
753Metastatic NeoplasmFAERS: 2US FAERS
754Monocyte count increasedFAERS: 2US FAERS
755Multi-organ disorderFAERS: 2US FAERS
756Multiple sclerosis relapseFAERS: 2US FAERS
757Neurological examination abnormalFAERS: 2US FAERS
758Ocular discomfortFAERS: 2US FAERS
759Oculomucocutaneous syndromeFAERS: 2US FAERS
760OliguriaFAERS: 2US FAERS
761Opiates positiveFAERS: 2US FAERS
762Optic NeuropathyFAERS: 2US FAERS
763OsteomyelitisFAERS: 2US FAERS
764OsteoporosisFAERS: 2US FAERS
765Pericardial effusionFAERS: 2US FAERS
766Perineal painFAERS: 2US FAERS
767Peripheral motor neuropathyFAERS: 2US FAERS
768Pharyngeal swellingFAERS: 2US FAERS
769PolyuriaFAERS: 2US FAERS
770Poor quality drug administeredFAERS: 2US FAERS
771Postural Orthostatic Tachycardia SyndromeFAERS: 2US FAERS
772Pressure of speechFAERS: 2US FAERS
773Procedural complicationFAERS: 2US FAERS
774Product complaintFAERS: 2US FAERS
775Product outer packaging issueFAERS: 2US FAERS
776Product taste abnormalFAERS: 2US FAERS
777Protein urine presentFAERS: 2US FAERS
778Pruritus allergicFAERS: 2US FAERS
779PseudolymphomaFAERS: 2US FAERS
780Psychomotor skills impairedFAERS: 2US FAERS
781Pulmonary FibrosisFAERS: 2US FAERS
782Pulmonary HypertensionFAERS: 2US FAERS
783Pulmonary toxicityFAERS: 2US FAERS
784PyuriaFAERS: 2US FAERS
785Radiation skin injuryFAERS: 2US FAERS
786Refusal of treatment by relativeFAERS: 2US FAERS
787Renal cystFAERS: 2US FAERS
788Respiratory fatigueFAERS: 2US FAERS
789Rheumatoid factor increasedFAERS: 2US FAERS
790SchizophreniaFAERS: 2US FAERS
791ScleritisFAERS: 2US FAERS
792Secretion dischargeFAERS: 2US FAERS
793Sinus Tarsi SyndromeFAERS: 2US FAERS
794Sinus bradycardiaFAERS: 2US FAERS
795Sjogren's SyndromeFAERS: 2US FAERS
796Skin IndurationFAERS: 2US FAERS
797Skin irritationFAERS: 2US FAERS
798SluggishnessFAERS: 2US FAERS
799Squamous cell carcinomaFAERS: 2US FAERS
800Staphylococcus test positiveFAERS: 2US FAERS
801Sudden deathFAERS: 2US FAERS
802Sudden onset of sleepFAERS: 2US FAERS
803SymblepharonFAERS: 2US FAERS
804Temporal ArteritisFAERS: 2US FAERS
805Tongue blisteringFAERS: 2US FAERS
806TracheobronchitisFAERS: 2US FAERS
807Transaminases abnormalFAERS: 2US FAERS
808TrichiasisFAERS: 2US FAERS
809TrichorrhexisFAERS: 2US FAERS
810Troponin I increasedFAERS: 2US FAERS
811Upper-airway cough syndromeFAERS: 2US FAERS
812Urine flow decreasedFAERS: 2US FAERS
813UveitisFAERS: 2US FAERS
814Venous ThrombosisFAERS: 2US FAERS
815Ventricular DysfunctionFAERS: 2US FAERS
816Ventricular hypokinesiaFAERS: 2US FAERS
817Viral upper respiratory tract infectionFAERS: 2US FAERS
818Abdominal InfectionFAERS: 1US FAERS
819Abdominal strangulated herniaFAERS: 1US FAERS
820Abdominal symptomFAERS: 1US FAERS
821Abnormal sleep-related eventFAERS: 1US FAERS
822Acid fast bacilli infectionFAERS: 1US FAERS
823AcidosisFAERS: 1US FAERS
824Acinetobacter test positiveFAERS: 1US FAERS
825Actinic keratosisFAERS: 1US FAERS
826Acute Coronary SyndromeFAERS: 1US FAERS
827Acute Lung InjuryFAERS: 1US FAERS
828Administration site reactionFAERS: 1US FAERS
829Agonal death struggleFAERS: 1US FAERS
830Alcohol IntoleranceFAERS: 1US FAERS
831Alcohol interactionFAERS: 1US FAERS
832Allergic sinusitisFAERS: 1US FAERS
833Alpha 2 globulin increasedFAERS: 1US FAERS
834Altered visual depth perceptionFAERS: 1US FAERS
835Anal discomfortFAERS: 1US FAERS
836AnhedoniaFAERS: 1US FAERS
837AnoxiaFAERS: 1US FAERS
838Anti-neutrophil cytoplasmic antibody positive vasculitisFAERS: 1US FAERS
839Anti-thyroid antibody positiveFAERS: 1US FAERS
840Antibiotic level below therapeuticFAERS: 1US FAERS
841Anticonvulsant drug level decreasedFAERS: 1US FAERS
842Antinuclear antibody increasedFAERS: 1US FAERS
843Antinuclear antibody negativeFAERS: 1US FAERS
844Aortic dissection ruptureFAERS: 1US FAERS
845AphakiaFAERS: 1US FAERS
846Aphthous StomatitisFAERS: 1US FAERS
847Aponeurosis contusionFAERS: 1US FAERS
848AppendicitisFAERS: 1US FAERS
849ArachnoiditisFAERS: 1US FAERS
850Arterial thrombosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
851Atrioventricular BlockFAERS: 1US FAERS
852Auricular swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
853AutophonyFAERS: 1US FAERS
854Axonal neuropathyFAERS: 1US FAERS
855Bacteria stool identifiedFAERS: 1US FAERS
856Bacterial sepsisFAERS: 1US FAERS
857BallismusFAERS: 1US FAERS
858Band neutrophil count increasedFAERS: 1US FAERS
859Basal cell carcinomaFAERS: 1US FAERS
860Biliary dilatationFAERS: 1US FAERS
861Biopsy muscle abnormalFAERS: 1US FAERS
862Bladder spasmFAERS: 1US FAERS
863BlastomycosisFAERS: 1US FAERS
864Blood alkaline phosphatase decreasedFAERS: 1US FAERS
865Blood cortisol decreasedFAERS: 1US FAERS
866Blood creatine phosphokinaseFAERS: 1US FAERS
867Blood creatinine abnormalFAERS: 1US FAERS
868Blood electrolytes abnormalFAERS: 1US FAERS
869Blood phosphorus decreasedFAERS: 1US FAERS
870Blood pressure inadequately controlledFAERS: 1US FAERS
871Blood pressure orthostatic decreasedFAERS: 1US FAERS
872Blood testosterone abnormalFAERS: 1US FAERS
873Blood testosterone decreasedFAERS: 1US FAERS
874Blood testosterone free decreasedFAERS: 1US FAERS
875Blood testosterone increasedFAERS: 1US FAERS
876Bone density decreasedFAERS: 1US FAERS
877Bronchial secretion retentionFAERS: 1US FAERS
878BronchiectasisFAERS: 1US FAERS
879Bronchopulmonary AspergillosisFAERS: 1US FAERS
880Burning feet syndromeFAERS: 1US FAERS
881Bursitis infective staphylococcalFAERS: 1US FAERS
882C-reactive protein abnormalFAERS: 1US FAERS
883CD30 expressionFAERS: 1US FAERS
884Caffeine consumptionFAERS: 1US FAERS
885CalcinosisFAERS: 1US FAERS
886Cardiac DeathFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
887Cardiac TamponadeFAERS: 1US FAERS
888Cardiac enzymes increasedFAERS: 1US FAERS
889CatatoniaFAERS: 1US FAERS
890Catheter site erythemaFAERS: 1US FAERS
891Catheter site pruritusFAERS: 1US FAERS
892Cauda Equina SyndromeFAERS: 1US FAERS
893Cerebral atrophyFAERS: 1US FAERS
894Chemical burn of skinFAERS: 1US FAERS
895Chemical injuryFAERS: 1US FAERS
896ChloropsiaFAERS: 1US FAERS
897CholangitisFAERS: 1US FAERS
898Cholecystitis infectiveFAERS: 1US FAERS
899Cholestatic liver injuryFAERS: 1US FAERS
900ChorioretinitisFAERS: 1US FAERS
901Chronic pigmented purpuraFAERS: 1US FAERS
902Clostridium difficile toxin test positiveFAERS: 1US FAERS
903Clostridium test positiveFAERS: 1US FAERS
904ClumsinessFAERS: 1US FAERS
905Complication associated with deviceFAERS: 1US FAERS
906Conduct DisorderFAERS: 1US FAERS
907ConfabulationFAERS: 1US FAERS
908Congenital neuropathyFAERS: 1US FAERS
909Conjunctival abrasionFAERS: 1US FAERS
910Conjunctival scarFAERS: 1US FAERS
911Contraindicated product prescribedFAERS: 1US FAERS
912Coronary Artery DiseaseFAERS: 1US FAERS
913Cortisol deficiencyFAERS: 1US FAERS
914Cortisol increasedFAERS: 1US FAERS
915Crystal urine presentFAERS: 1US FAERS
916Culture wound positiveFAERS: 1US FAERS
917Cutis LaxaFAERS: 1US FAERS
918DacryocanaliculitisFAERS: 1US FAERS
919Dacryostenosis acquiredFAERS: 1US FAERS
920Dark circles under eyesFAERS: 1US FAERS
921Decreased immune responsivenessFAERS: 1US FAERS
922Dehydroepiandrosterone decreasedFAERS: 1US FAERS
923DemyelinationFAERS: 1US FAERS
924Dental PlaqueFAERS: 1US FAERS
925Dental cariesFAERS: 1US FAERS
926Dermatitis HerpetiformisFAERS: 1US FAERS
927Dermatitis acneiformFAERS: 1US FAERS
928DermatomyositisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
929Device FailureFAERS: 1US FAERS
930Diabetic KetoacidosisFAERS: 1US FAERS
931Diabetic foot infectionFAERS: 1US FAERS
932DiaphragmalgiaFAERS: 1US FAERS
933Diastolic dysfunctionFAERS: 1US FAERS
934DiplegiaFAERS: 1US FAERS
935Disease risk factorFAERS: 1US FAERS
936DiverticulumFAERS: 1US FAERS
937Dropped head syndromeFAERS: 1US FAERS
938Drug DependenceFAERS: 1US FAERS
939Drug administered to patient of inappropriate ageFAERS: 1US FAERS
940Drug dose titration not performedFAERS: 1US FAERS
941Drug effect incompleteFAERS: 1US FAERS
942Drug exposure via breast milkFAERS: 1US FAERS
943Drug level above therapeuticFAERS: 1US FAERS
944Drug level changedFAERS: 1US FAERS
945Drug level increasedFAERS: 1US FAERS
946DuodenitisFAERS: 1US FAERS
947Duodenogastric RefluxFAERS: 1US FAERS
948Ear congestionFAERS: 1US FAERS
949Ectopic PregnancyFAERS: 1US FAERS
950Ejection Fraction DecreasedFAERS: 1US FAERS
951Elevated moodFAERS: 1US FAERS
952Enamel anomalyFAERS: 1US FAERS
953EndocarditisFAERS: 1US FAERS
954Endotracheal intubation complicationFAERS: 1US FAERS
955Enterococcal infectionFAERS: 1US FAERS
956Enterovirus test positiveFAERS: 1US FAERS
957EnuresisFAERS: 1US FAERS
958Eosinophil percentage increasedFAERS: 1US FAERS
959EpidermolysisFAERS: 1US FAERS
960Epigastric discomfortFAERS: 1US FAERS
961Erythrodermic psoriasisFAERS: 1US FAERS
962Essential HypertensionFAERS: 1US FAERS
963Excessive eye blinkingFAERS: 1US FAERS
964ExcoriationFAERS: 1US FAERS
965Exposure to toxic agentFAERS: 1US FAERS
966Exposure to unspecified agentFAERS: 1US FAERS
967Extra dose administeredFAERS: 1US FAERS
968Extraocular Muscle ParesisFAERS: 1US FAERS
969Extremity necrosisFAERS: 1US FAERS
970Eye inflammationFAERS: 1US FAERS
971Eyelid Function DisorderFAERS: 1US FAERS
972Eyelid painFAERS: 1US FAERS
973Eyelids pruritusFAERS: 1US FAERS
974Facial NeuralgiaFAERS: 1US FAERS
975Facial ParesisFAERS: 1US FAERS
976Facial paralysisFAERS: 1US FAERS
977Factor VII DeficiencyFAERS: 1US FAERS
978Factor VIII DeficiencyFAERS: 1US FAERS
979False negative investigation resultFAERS: 1US FAERS
980False positive laboratory resultFAERS: 1US FAERS
981Fear of fallingFAERS: 1US FAERS
982Feelings of worthlessnessFAERS: 1US FAERS
983FibrosisFAERS: 1US FAERS
984FilariasisFAERS: 1US FAERS
985Fluid overloadFAERS: 1US FAERS
986Foaming at mouthFAERS: 1US FAERS
987Food PoisoningFAERS: 1US FAERS
988Food aversionFAERS: 1US FAERS
989Foreign body in respiratory tractFAERS: 1US FAERS
990FrostbiteFAERS: 1US FAERS
991Gallbladder painFAERS: 1US FAERS
992Gastric DilatationFAERS: 1US FAERS
993Gastric infectionFAERS: 1US FAERS
994Gastric pH decreasedFAERS: 1US FAERS
995Gastric ulcerFAERS: 1US FAERS
996Gastrointestinal amyloidosisFAERS: 1US FAERS
997Gastrointestinal bacterial infectionFAERS: 1US FAERS
998Gastrointestinal sounds abnormalFAERS: 1US FAERS
999GastrostomyFAERS: 1US FAERS
1000General symptomFAERS: 1US FAERS
1001Genital abscessFAERS: 1US FAERS
1002Genital discomfortFAERS: 1US FAERS
1003Genital erythemaFAERS: 1US FAERS
1004Gingival RecessionFAERS: 1US FAERS
1005GlomerulonephritisFAERS: 1US FAERS
1006Glossopharyngeal nerve paralysisFAERS: 1US FAERS
1007Guttate psoriasisFAERS: 1US FAERS
1008Heart sounds abnormalFAERS: 1US FAERS
1009HemiparesisFAERS: 1US FAERS
1010Hepatitis C antibody positiveFAERS: 1US FAERS
1011Hepatitis C virus test positiveFAERS: 1US FAERS
1012HidradenitisFAERS: 1US FAERS
1013Histone antibodyFAERS: 1US FAERS
1014HostilityFAERS: 1US FAERS
1015Human EhrlichiosisFAERS: 1US FAERS
1016Humoral immune defectFAERS: 1US FAERS
1017HydronephrosisFAERS: 1US FAERS
1018HyperchlorhydriaFAERS: 1US FAERS
1019HypercreatinaemiaFAERS: 1US FAERS
1020HyperkinesiaFAERS: 1US FAERS
1021HyperoxaluriaFAERS: 1US FAERS
1022HyperthyroidismFAERS: 1US FAERS
1023HypohidrosisFAERS: 1US FAERS
1024HypomaniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1025HypoperfusionFAERS: 1US FAERS
1026Hyporesponsive to stimuliFAERS: 1US FAERS
1027Idiopathic angioedemaFAERS: 1US FAERS
1028Idiopathic urticariaFAERS: 1US FAERS
1029Illogical thinkingFAERS: 1US FAERS
1030ImmunosuppressionFAERS: 1US FAERS
1031ImpatienceFAERS: 1US FAERS
1032ImpetigoFAERS: 1US FAERS
1033Inappropriate affectFAERS: 1US FAERS
1034Inappropriate schedule of product administrationFAERS: 1US FAERS
1035Incision site vesiclesFAERS: 1US FAERS
1036Incorrect drug dosage form administeredFAERS: 1US FAERS
1037Incorrect route of drug administrationFAERS: 1US FAERS
1038Increased bronchial secretionFAERS: 1US FAERS
1039Increased upper airway secretionFAERS: 1US FAERS
1040Increased viscosity of bronchial secretionFAERS: 1US FAERS
1041Increased viscosity of nasal secretionFAERS: 1US FAERS
1042InfarctionFAERS: 1US FAERS
1043Infection reactivationFAERS: 1US FAERS
1044Inflammatory painFAERS: 1US FAERS
1045Infrequent bowel movementsFAERS: 1US FAERS
1046Infusion site burningFAERS: 1US FAERS
1047Infusion site irritationFAERS: 1US FAERS
1048Infusion site streakingFAERS: 1US FAERS
1049Injection site irritationFAERS: 1US FAERS
1050Injection site thrombosisFAERS: 1US FAERS
1051Injection site urticariaFAERS: 1US FAERS
1052Intentional dose omissionFAERS: 1US FAERS
1053Intentional misuseFAERS: 1US FAERS
1054Intercepted drug dispensing errorFAERS: 1US FAERS
1055Intercepted wrong patient selectedFAERS: 1US FAERS
1056Intervertebral disc compressionFAERS: 1US FAERS
1057Intestinal ObstructionFAERS: 1US FAERS
1058Intestinal PerforationFAERS: 1US FAERS
1059Intraspinal abscessFAERS: 1US FAERS
1060IritisFAERS: 1US FAERS
1061Japanese Spotted FeverFAERS: 1US FAERS
1062Jugular vein distensionFAERS: 1US FAERS
1063Keratoconjunctivitis SiccaFAERS: 1US FAERS
1064Klebsiella test positiveFAERS: 1US FAERS
1065Lacrimation decreasedFAERS: 1US FAERS
1066Lactose IntoleranceFAERS: 1US FAERS
1067Laryngeal neoplasmFAERS: 1US FAERS
1068LazinessFAERS: 1US FAERS
1069Lens dislocationFAERS: 1US FAERS
1070Limb massFAERS: 1US FAERS
1071Limb operationFAERS: 1US FAERS
1072Lip erosionFAERS: 1US FAERS
1073Lipase increasedFAERS: 1US FAERS
1074ListeriosisFAERS: 1US FAERS
1075Lobar PneumoniaFAERS: 1US FAERS
1076Local reactionFAERS: 1US FAERS
1077Long QT SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1078Lumbar puncture abnormalFAERS: 1US FAERS
1079Lung InjuryFAERS: 1US FAERS
1080LymphadenitisFAERS: 1US FAERS
1081Lymphangiosis carcinomatosaFAERS: 1US FAERS
1082Lymphocyte percentage decreasedFAERS: 1US FAERS
1083LymphocytosisFAERS: 1US FAERS
1084LymphomaFAERS: 1US FAERS
1085MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
1086MacrocytosisFAERS: 1US FAERS
1087Magnesium DeficiencyFAERS: 1US FAERS
1088Malignant neoplasm progressionFAERS: 1US FAERS
1089Maternal exposure during pregnancyFAERS: 1US FAERS
1090Medical device site reactionFAERS: 1US FAERS
1091MegacolonFAERS: 1US FAERS
1092MeningismFAERS: 1US FAERS
1093MeningitisFAERS: 1US FAERS
1094Mental disorder due to a general medical conditionFAERS: 1US FAERS
1095Metabolic acidosisFAERS: 1US FAERS
1096MetastasisFAERS: 1US FAERS
1097MetatarsalgiaFAERS: 1US FAERS
1098Micturition frequency decreasedFAERS: 1US FAERS
1099Migraine with AuraFAERS: 1US FAERS
1100MiliariaFAERS: 1US FAERS
1101Mitochondrial myopathy acquiredFAERS: 1US FAERS
1102MoaningFAERS: 1US FAERS
1103Mononeuropathy MultiplexFAERS: 1US FAERS
1104MonoparesisFAERS: 1US FAERS
1105Myasthenic SyndromeFAERS: 1US FAERS
1106MyelitisFAERS: 1US FAERS
1107MyocarditisFAERS: 1US FAERS
1108MyofascitisFAERS: 1US FAERS
1109NarcolepsyFAERS: 1US FAERS
1110Neurological eyelid disorderFAERS: 1US FAERS
1111NeuromaFAERS: 1US FAERS
1112Neutrophil count abnormalFAERS: 1US FAERS
1113NocturiaFAERS: 1US FAERS
1114Non-cardiac chest painFAERS: 1US FAERS
1115Nutritional condition abnormalFAERS: 1US FAERS
1116NystagmusFAERS: 1US FAERS
1117Occult blood positiveFAERS: 1US FAERS
1118Occupational exposure to productFAERS: 1US FAERS
1119Ocular vascular disorderFAERS: 1US FAERS
1120Oculogyric crisisFAERS: 1US FAERS
1121OnychoclasisFAERS: 1US FAERS
1122Optic AtrophyFAERS: 1US FAERS
1123Oral mucosal eruptionFAERS: 1US FAERS
1124Oral pruritusFAERS: 1US FAERS
1125Oral pustuleFAERS: 1US FAERS
1126OrchitisFAERS: 1US FAERS
1127Oropharyngeal discomfortFAERS: 1US FAERS
1128Orthodontic appliance userFAERS: 1US FAERS
1129OsteitisFAERS: 1US FAERS
1130OsteochondrosisFAERS: 1US FAERS
1131OtotoxicityFAERS: 1US FAERS
1132ParasomniaFAERS: 1US FAERS
1133ParotitisFAERS: 1US FAERS
1134Partner stressFAERS: 1US FAERS
1135Patient IsolationFAERS: 1US FAERS
1136Penile blisterFAERS: 1US FAERS
1137Penile erythemaFAERS: 1US FAERS
1138Perforated ulcerFAERS: 1US FAERS
1139Periorbital contusionFAERS: 1US FAERS
1140PertussisFAERS: 1US FAERS
1141Phantom painFAERS: 1US FAERS
1142Pharyngolaryngeal discomfortFAERS: 1US FAERS
1143PiloerectionFAERS: 1US FAERS
1144PleurisyFAERS: 1US FAERS
1145Pleuritic painFAERS: 1US FAERS
1146Pneumococcal sepsisFAERS: 1US FAERS
1147PoliomyelitisFAERS: 1US FAERS
1148Polyarteritis NodosaFAERS: 1US FAERS
1149Portal fibrosisFAERS: 1US FAERS
1150Post procedural painFAERS: 1US FAERS
1151Postoperative infectionFAERS: 1US FAERS
1152Pregnancy of partnerFAERS: 1US FAERS
1153PregnancyFAERS: 1US FAERS
1154Procedural nauseaFAERS: 1US FAERS
1155Procedural site reactionFAERS: 1US FAERS
1156Procedural vomitingFAERS: 1US FAERS
1157Product administered to patient of inappropriate ageFAERS: 1US FAERS
1158Product administration errorFAERS: 1US FAERS
1159Product appearance confusionFAERS: 1US FAERS
1160Product dispensing errorFAERS: 1US FAERS
1161Product label confusionFAERS: 1US FAERS
1162Product lot number issueFAERS: 1US FAERS
1163Product name confusionFAERS: 1US FAERS
1164Product packaging issueFAERS: 1US FAERS
1165Product prescribing issueFAERS: 1US FAERS
1166Product used for unknown indicationFAERS: 1US FAERS
1167Psychological TraumaFAERS: 1US FAERS
1168Pulmonary EosinophiliaFAERS: 1US FAERS
1169Pulmonary InfarctionFAERS: 1US FAERS
1170Pulmonary congestionFAERS: 1US FAERS
1171Pulmonary painFAERS: 1US FAERS
1172Pulmonary thrombosisFAERS: 1US FAERS
1173Pulmonary trichosporonosisFAERS: 1US FAERS
1174Purulent dischargeFAERS: 1US FAERS
1175PyelonephritisFAERS: 1US FAERS
1176Pyoderma GangrenosumFAERS: 1US FAERS
1177Radial Tunnel SyndromeFAERS: 1US FAERS
1178Radial nerve compressionFAERS: 1US FAERS
1179Radiation injuryFAERS: 1US FAERS
1180RadiculopathyFAERS: 1US FAERS
1181Reaction to drug excipientsFAERS: 1US FAERS
1182Reaction to preservativesFAERS: 1US FAERS
1183Recall phenomenonFAERS: 1US FAERS
1184Rectal dischargeFAERS: 1US FAERS
1185RegurgitationFAERS: 1US FAERS
1186Relapsing FeverFAERS: 1US FAERS
1187Renal aneurysmFAERS: 1US FAERS
1188Renal massFAERS: 1US FAERS
1189Renal tubular necrosisFAERS: 1US FAERS
1190Respiratory tract congestionFAERS: 1US FAERS
1191Resting TremorFAERS: 1US FAERS
1192Retinal Artery OcclusionFAERS: 1US FAERS
1193Retinal scarFAERS: 1US FAERS
1194Retinal vascular thrombosisFAERS: 1US FAERS
1195RicketsFAERS: 1US FAERS
1196Romberg test positiveFAERS: 1US FAERS
1197SacroiliitisFAERS: 1US FAERS
1198Salt cravingFAERS: 1US FAERS
1199Sensory processing disorderFAERS: 1US FAERS
1200Skin WrinklingFAERS: 1US FAERS
1201Skin noduleFAERS: 1US FAERS
1202Sleep TalkingFAERS: 1US FAERS
1203Sleep disorder due to a general medical conditionFAERS: 1US FAERS
1204Slow speechFAERS: 1US FAERS
1205Soft tissue necrosisFAERS: 1US FAERS
1206Spinal column stenosisFAERS: 1US FAERS
1207Spinal fusion surgeryFAERS: 1US FAERS
1208Splenic RuptureFAERS: 1US FAERS
1209SpondylitisFAERS: 1US FAERS
1210SpondylolisthesisFAERS: 1US FAERS
1211Status AsthmaticusFAERS: 1US FAERS
1212Stenotrophomonas infectionFAERS: 1US FAERS
1213Stent malfunctionFAERS: 1US FAERS
1214StrabismusFAERS: 1US FAERS
1215Subcutaneous AbscessFAERS: 1US FAERS
1216Sudden Cardiac DeathFAERS: 1US FAERS
1217SuperinfectionFAERS: 1US FAERS
1218Tendon sheath disorderFAERS: 1US FAERS
1219Testicular massFAERS: 1US FAERS
1220Thirst decreasedFAERS: 1US FAERS
1221ThymomaFAERS: 1US FAERS
1222Tilt table test positiveFAERS: 1US FAERS
1223Tongue exfoliationFAERS: 1US FAERS
1224Tooth InfectionFAERS: 1US FAERS
1225Torus fractureFAERS: 1US FAERS
1226Toxic Optic NeuropathyFAERS: 1US FAERS
1227Toxic Shock SyndromeFAERS: 1US FAERS
1228Transcription medication errorFAERS: 1US FAERS
1229Trigeminal Nerve DisorderFAERS: 1US FAERS
1230Trigeminal NeuralgiaFAERS: 1US FAERS
1231Tryptase increasedFAERS: 1US FAERS
1232TuberculosisFAERS: 1US FAERS
1233Ulnar NeuritisFAERS: 1US FAERS
1234UnderweightFAERS: 1US FAERS
1235UnemploymentFAERS: 1US FAERS
1236Unequal Limb LengthFAERS: 1US FAERS
1237Upper respiratory tract inflammationFAERS: 1US FAERS
1238Urinary tract infection enterococcalFAERS: 1US FAERS
1239Urinary tract obstructionFAERS: 1US FAERS
1240Urine ketone body presentFAERS: 1US FAERS
1241Urine output increasedFAERS: 1US FAERS
1242Uterovaginal prolapseFAERS: 1US FAERS
1243Vaginal ProlapseFAERS: 1US FAERS
1244Vaginal burning sensationFAERS: 1US FAERS
1245Vaginal painFAERS: 1US FAERS
1246Vascular fragilityFAERS: 1US FAERS
1247Vascular insufficiencyFAERS: 1US FAERS
1248VasospasmFAERS: 1US FAERS
1249Vein painFAERS: 1US FAERS
1250Venous InjuryFAERS: 1US FAERS
1251Ventricular hypertrophyFAERS: 1US FAERS
1252Vestibular NeuronitisFAERS: 1US FAERS
1253Violence-related symptomFAERS: 1US FAERS
1254Vital functions abnormalFAERS: 1US FAERS
1255Vitamin B1 decreasedFAERS: 1US FAERS
1256Vitreous lossFAERS: 1US FAERS
1257Vulvovaginal burning sensationFAERS: 1US FAERS
1258White blood cell count abnormalFAERS: 1US FAERS
1259Wound InfectionFAERS: 1US FAERS
1260Wound dehiscenceFAERS: 1US FAERS
1261fibromaFAERS: 1US FAERS
1262heart rateFAERS: 1US FAERS
1263Bacterial Infections22211524CTD
1264Chemical and Drug Induced Liver Injury22891208
24085192
24865821
CTD
1265Hepatorenal SyndromeCanada Vigilance: 1Canada Vigilance
1266Injection site inflammationCanada Vigilance: 1Canada Vigilance
1267Product prescribing errorCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.